edrugsearch.com
The Wal-Mart effect
Even though pharmacy giants like CVS and Walgreens have denied that Wal-Mart's $4 drug plan has affected sales, Walgreens stock has slumped by 15 percent, and the chain has announced lower-than-expected third quarter earnings. According to Peter Rost at Brandweek NRX, weaker margins on generic